Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Synthon, 3 Aug 2015
Accessed on 5 Aug 2015 from http://www.synthon.com/Corporate/News/PressReleases/Pfizer-and-Synthon-Enter-Into-US-Commercialization-Agreement-for-Potential-Generic-Treatment-of-MS.aspx.